Week of June 13, 2023 | Vol. 12, Issue 23

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

DIA Global 2023

June 25-29, 2023 - Boson, MA

Contract Pharma 2023

September 5-8, 2023 - New Brunswick, NJ

Bourne Partners Annual Summit 2023

Invitation Only

October 4, 2023 - Charlotte, NC

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A Transactions

Pharma & Biotech

11 transactions totaling $1.1 billion


Supplies, Equipment & Services

33 transactions totaling $5.0 billion


Healthcare Facilities & Distributors

12 transactions totaling $78 million


Healthcare IT & Managed Care

10 transactions totaling $115 million

Private Placements

Pharma & Biotech

32 transactions totaling $832 million


Supplies, Equipment & Services

19 transactions totaling $286 million


Healthcare Facilities & Distributors

3 transactions


Healthcare IT & Managed Care

12 transactions totaling $149 million

Public Offerings

Pharma & Biotech

26 transactions totaling $1.4 billion


Supplies, Equipment & Services

9 transactions totaling $2.6 billion


Healthcare Facilities & Distributors

3 transactions totaling $995 million


Healthcare IT & Managed Care

0 transactions

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings

PR Newswire - Jun 5, 2023

Flatiron welds deal with Lifebit to leverage AI in tracking cancer data

Fierce Biotech - Jun 5, 2023

Fosun Pharma and IFC Partner to Improve Access to High Quality Medicines in Africa

PR Newswire - Jun 6, 2023

GenScript ProBio and Comprehensive Cell Solutions, a Business Unit of the New York Blood Center Enterprises, Form a Pioneering Partnership to Expedite Cell and Gene Therapy Development and Manufacturing

Business Wire - Jun 7, 2023

CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023

DCAT Value Chain Insights - Jun 8, 2023

Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio

Samsung Biologics - Jun 8, 2023

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration

Business Wire - Jun 8, 2023

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB - Jun 8, 2023

LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business.

LTS Lohmann - Jun 8, 2023

Novartis adds $3.2B cash deal to M&A tally, snapping up Chinook and its late-stage kidney drugs

Endpoints News - Jun 12, 2023

TANNER NEWS

Linkedin  

Tanner Announces New US Operations Facility


Tanner Pharma is embarking on a new chapter of growth and expansion with the start of construction for a new operations facility in Charlotte, NC USA. Learn more.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.